Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer.
Cancers
Chen M, Li Y, Wu Y, Xie S, Ma J, Yue J, Lv R, Tian Z, Fang F, Xiao W.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2021
Cancer Research
Immunology
No items found.
Key Finding
Numerous reports indicate that NK cell immunotherapy is an effective therapeutic approach for treating hematological malignancies, but shows limited effects against solid tumors. These data show that eNK cell immunotherapy could be a promising treatment strategy for ovarian cancers, including solid tumors and ascites.
Countstar Connection
The researchers measured cell numbers in the study's cell samples with Countstar (model not specified) during quality assessment in the 2021 Cancers study.
